Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Image

[Articles] Efficacy and safety of dabrafenib plus trametinib in adults with differentiated thyroid cancer: a randomised, double-blind, placebo-controlled, phase 3 trial

Journal content Created on 14 Jul 2026 The Lancet Oncology

Published in

The Lancet Oncology, The Lancet (Reed Elsevier)

Content

There is no additional content. Please click on the source link to view more information.

Ming Gao, Young Joo Park, Chia-Chi Lin, Monika K Krzyzanowska, Zhiyong Li, Hui-Jen Tsai, Feng Shi, Jianwu Qin, Swee Hsia Choong, Yansong Lin, Yuan Zhang, Jin H Kang, Ana O Hoff, Monique Tan, Michael Roughton, Michaela Paul, Lori J Wirth

Advertisement

Stats

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement